All posts by : Felistas

About 40% of households in the United States report firearm access and the majority of firearm owners report typically storing at least one of their firearms unsecured.

For many patients, getting ready to have surgery means getting their blood drawn, their heart rhythm checked, or having other tests in the weeks leading up to their operation.

A group of scientists in China has revealed a novel mechanism whereby a short form of IL-18, generated by caspase-3 cleavage in tumor cells, activates natural killer (NK) cells to suppress tumor growth, offering new therapeutic opportunities. The research is published in the journal Nature Immunology.

New research led by experts at the University of Nottingham calls for greater awareness of the symptoms of bone cancers in children and young adults.

Electroencephalography (EEG) may offer a more accessible alternative to functional magnetic resonance imaging (fMRI) for guiding transcranial direct current stimulation (tDCS) when treating aphasia. Researchers from the Institute of Science Tokyo have found an 80% agreement between EEG and fMRI in identifying brain regions activated during language tasks. Furthermore, EEG-guided tDCS improved picture-naming speed in participants, indicating its potential for innovative therapies in language disorders.

Researchers at the Ernst Strüngmann Institute in Frankfurt am Main, Germany, led by Wolf Singer, have made a new discovery in understanding fundamental brain processes. For the first time, the team has provided compelling evidence that the brain’s characteristic rhythmic patterns play a crucial role in information processing. While these oscillatory dynamics have long been observed in the brain, their purpose has remained mostly elusive until now.

The percentage of wildfire-associated emergency department encounters increased with onset of the Los Angeles County (LAC) wildfires in January 2025, according to research published in the Feb. 6 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced Parkinson disease, according to a news release from Supernus Pharmaceuticals.

In a novel theory, scientists at Arizona State University’s Biodesign Institute propose a unifying explanation for the molecular chaos driving Alzheimer’s disease. The condition causes widespread disruption of gene behavior, affecting every known neuropathology and clinical manifestation of the disease.

Nearly every disease has an inflammatory component, but blood tests can’t pinpoint inflammation in specific organs or tissues in the human body.